Medicare AdvantageDocumentationHigh impact
Coding Newsletter - Asthma
Florida Blue·FL · Pulmonology, Pediatrics, Family Medicine +5 more·Coding
Effective date
Jun 1, 2026
We identified it
Jul 9, 2026
Summary
This is a comprehensive coding newsletter update on asthma diagnosis and documentation requirements effective June 2026. It emphasizes the critical distinction between asthma severity (mild/moderate/severe) and current control status, requiring providers to document both to ensure accurate ICD-10-CM coding. Billing teams must enforce complete documentation including severity, persistence, exacerbation status, and status asthmaticus to support proper code assignment (J45.2-J45.52 series) and capture associated conditions like eosinophilic asthma (J82.83).
Action Required
By June 1, 2026: Providers must begin documenting BOTH asthma severity (mild intermittent/persistent, moderate persistent, severe persistent) AND current clinical status (stable/well-controlled, acute exacerbation, status asthmaticus) at every asthma encounter. Billing team must update encounter forms, templates, and EMR systems to include mandatory fields for: (1) severity classification, (2) control status, (3) exacerbation presence, (4) status asthmaticus if applicable, (5) eosinophilic asthma indicator, and (6) tobacco/vaping exposure. Create billing rules in practice management system to deny/hold claims missing any of these required documentation elements and route to providers for completion before submission. Train all clinical staff on the asthma documentation checklist provided in the policy. Update coding guidelines for billing coders to reference the decision tree for code assignment based on severity + status combinations. Consequences: Claims with incomplete asthma documentation will be rejected, causing payment delays and potential compliance issues with Medicare Advantage risk adjustment audits.